IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer

Differentiated thyroid cancer (DTC) is the most frequent endocrine tumor with a good prognosis after primary treatment in most cases. By contrast, 30–40% of patients with metastatic DTC are unresponsive to (131)I radioactive iodide (RAI) treatment due to tumor dedifferentiation. Currently, underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Crezee, Thomas, Tesselaar, Marika H., Jaeger, Martin, Rabold, Katrin, Corver, Willem E., Morreau, Hans, Van Engen-Van Grunsven, Adriana C.H., Smit, Jan W.A., Netea-Maier, Romana T., Plantinga, Theo S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200939/
https://www.ncbi.nlm.nih.gov/pubmed/34149901
http://dx.doi.org/10.3892/ol.2021.12851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200939/
https://www.ncbi.nlm.nih.gov/pubmed/34149901
http://dx.doi.org/10.3892/ol.2021.12851

Ejemplares similares